NLRP3 and Parkinson disease: We look forward to the exciting progress of nanotechnology sciences and basic biology, together with the growing knowledge concerning the role of specific innate immune receptors and inflammation in PD and the translational studies of TLRs and NLRP3/Cas-1 inhibitors.